Cargando…

Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study

Spasticity is one of the most disabling symptoms in multiple sclerosis (MS). Botulinum toxin injection (BTI) is a first-line treatment for focal spasticity. There is a lack of evidence of a functional improvement following BTI in MS-related spasticity. To describe goal-setting for BTI in MS, and eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baccouche, Ines, Bensmail, Djamel, Leblong, Emilie, Fraudet, Bastien, Aymard, Claire, Quintaine, Victorine, Pottier, Sandra, Lansaman, Thibaud, Malot, Claire, Gallien, Philippe, Levy, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504895/ https://www.ncbi.nlm.nih.gov/pubmed/36136520 http://dx.doi.org/10.3390/toxins14090582

Ejemplares similares

Cost effectiveness of a telerehabilitation intervention vs home based care for adults with severe neurologic disability: A randomized clinical trial
por: Duruflé, Aurélie, et al.
Publicado: (2023)

Influence de la crise sanitaire COVID-19 sur la perception de la télérééducation dans la population des kinésithérapeutes français, une étude qualitative
por: Le Toullec, Elodie, et al.
Publicado: (2022)

SWADAPT1: assessment of an electric wheelchair-driving robotic module in standardized circuits: a prospective, controlled repeated measure design pilot study
por: Leblong, Emilie, et al.
Publicado: (2021)

Evaluation of a Digitally Guided Self-Rehabilitation Device Coupled With Telerehabilitation Monitoring in Patients With Parkinson Disease (TELEP@RK): Open, Prospective Observational Study
por: Blanc, Margaux, et al.
Publicado: (2022)

Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
por: Levy, Jonathan, et al.
Publicado: (2023)

Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, investigator blinded study
por: Bonnyaud, Celine, et al.
Publicado: (2018)

EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
por: BIERING-SØRENSEN, Bo, et al.
Publicado: (2021)

The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021)

A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE SPASTICITY INTERVENTIONS WITH BOTULINUM TOXIN A: AN INTERNATIONAL GROUP CONSENSUS
por: FRANCISCO, Gerard E., et al.
Publicado: (2020)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
por: Bensmail, Djamel, et al.
Publicado: (2023)

The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia
por: Chen, Yen-Ting, et al.
Publicado: (2020)

Goal Attainment: A Clinically Meaningful Measure of Success of Botulinum Toxin-A Treatment for Lower Limb Spasticity in Ambulatory Patients
por: Choudhry, Subbuh, et al.
Publicado: (2021)

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)

Effect of botulinum toxin type-A in patients with focal spasticity
por: Selimoglu, Esra, et al.
Publicado: (2015)

Spasticity treatment with botulinum toxin during the COVID-19 pandemic
por: Branquinho, Lurdes Rovisco, et al.
Publicado: (2021)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Telerehabilitation during the COVID-19 pandemic, what are the determinants of satisfaction for chronic diseases? a retrospective study
por: Roy, Anne laure, et al.
Publicado: (2023)

A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting
por: Jacinto, Jorge, et al.
Publicado: (2022)

When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
por: Gracies, Jean-Michel, et al.
Publicado: (2020)

Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
por: Kaku, Michelle, et al.
Publicado: (2016)

Treatment diary for botulinum toxin spasticity treatment: a pilot study
por: Biering-Sørensen, Bo, et al.
Publicado: (2017)

Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX)
por: Supiot, Anthony, et al.
Publicado: (2018)

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
por: Rekand, Tiina, et al.
Publicado: (2019)

GOAL ATTAINMENT SCALING IN REHABILITATION: AN EDUCATIONAL REVIEW PROVIDING A COMPREHENSIVE DIDACTICAL TOOL BOX FOR IMPLEMENTING GOAL ATTAINMENT SCALING
por: BARD-PONDARRÉ, Rachel, et al.
Publicado: (2023)

Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013)

Botulinum Toxin Injection for Spastic Scapular Dyskinesia After Stroke: Case Series
por: Hou, Saiyun, et al.
Publicado: (2015)

Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity
por: Roncoroni, Lorenzo Pietro, et al.
Publicado: (2020)

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury
por: Palazón-García, Ramiro, et al.
Publicado: (2021)

Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity
por: Veverka, Tomáš, et al.
Publicado: (2021)

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

LONGITUDINAL GOAL ATTAINMENT WITH INTEGRATED UPPER LIMB SPASTICITY MANAGEMENT INCLUDING REPEAT INJECTIONS OF BOTULINUM TOXIN A: FINDINGS FROM THE PROSPECTIVE, OBSERVATIONAL UPPER LIMB INTERNATIONAL SPASTICITY (ULIS-III) COHORT STUDY
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

ONLINE MONITORING OF FOCAL SPASTICITY TREATMENT WITH BOTULINUM TOXIN IN PEOPLE WITH CHRONIC STROKE OR HEREDITARY SPASTIC PARAPLEGIA: A FEASIBILITY STUDY
por: KERSTENS, Hans C. J. W., et al.
Publicado: (2023)

A Literature Review on the Efficacy and Safety of Botulinum Toxin: An Injection in Post-Stroke Spasticity
por: Ghasemi, Majid, et al.
Publicado: (2013)

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series
por: Lester, Jacobo, et al.
Publicado: (2018)

Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia
por: Paparella, Gabriella, et al.
Publicado: (2020)

Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity
por: Ghroubi, Sameh, et al.
Publicado: (2020)

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
por: Dressler, Dirk, et al.
Publicado: (2021)

Spinal plasticity in stroke patients after botulinum neurotoxin A injection in ankle plantar flexors
por: Aymard, Claire, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2vb8j1j1bu5bf4ll7iotvtr3q9